...
首页> 外文期刊>Acta Cardiologica >Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary aogiography or angioplasty: a randomized clinical trial
【24h】

Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary aogiography or angioplasty: a randomized clinical trial

机译:口服和静脉水合作用策略预防冠状动脉造影或血管成形术患者对比剂诱发的肾病的比较:一项随机临床试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The efficacy of oral hydration in the prevention of contrast-induced nephropathy in patients undergoing elective coronary intervention is unclear.A total of 120 patients were randomly assigned to three groups. Group A (n=40) received intravenous hydration before and after coronary angiography or angioplasty. Group B (n=40) received oral tap water before and after the procedures, whereas group C (n=40) received only post-procedural drinking water. Levels of serum creatinine and urea nitrogen were measured before, 12 hours after, 2 and 3 days after the coronary angiography or angioplasty.There was no statistically significant difference in the age, sex, baseline renal function and the volume of contrast medium used during the coronary procedures among the three groups (P>0.05). There was no statistically significant difference in the mean serum creatinine or urea nitrogen among the three groups 12 hours, 2 and 3 days after the coronary procedures (P > 0.05).The incidence of contrast-induced nephropathy in group A, B and C was 5.0% (2/40), 7.5% (3/40) and 5.0% (2/40), respectively (P=0.86). Renal function in the seven patients who experienced contrast-induced nephropathy recovered within a week following rehydration treatment.Pre- and post-procedural oral hydration was as effective as intravenous rehydration in the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty.
机译:目前尚不清楚口服水合作用对预防性择期冠状动脉介入治疗患者的造影剂诱发的肾病的疗效。共有120例患者随机分为三组。 A组(n = 40)在冠状动脉造影或血管成形术之前和之后接受了静脉补液。 B组(n = 40)在手术前后均接受口服自来水,而C组(n = 40)仅在术后接受饮用水。在冠状动脉造影或血管成形术之前,之后12小时,之后2和3天测量血清肌酐和尿素氮的水平,在年龄,性别,基线肾功能和造影剂使用期间造影剂的体积方面无统计学差异。三组之间的冠状动脉手术之间(P> 0.05)。冠状动脉手术后12小时,2和3天,三组的平均血清肌酐或尿素氮无统计学差异(P> 0.05).A,B和C组造影剂诱发的肾病发生率分别为5.0%(2/40),7.5%(3/40)和5.0%(2/40)(P = 0.86)。在补液治疗后一周内,七名经历对比剂诱发的肾病的患者的肾功能得以恢复。术前和术后口服补液在预防冠状动脉造影或血管成形术患者的对比剂诱发的肾病方面与静脉补液一样有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号